Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Biotricity is a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Vivita Technologies develops biomaterials for regenerative medicine, intending to alleviate the scarcity of donor organs and tissues.
Ontogen Medtech is a medical device development firm.
I CORDIS is a healthcare organization that offers services for treating heart failure.
WynnVision is a technology based company.
SeaStar Medical is a commercial-stage medical device company that develops immunomodulating technologies.
Life sciences R&D, consulting and investment
Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.
Lazzaro Medical is to assist the millions of patients who have tracheobronchomalacia (TBM).
Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
VoluMetrix is dedicated to developing breakthrough monitoring technologies to enhance people's well-being.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Generating digital biomarkers for women's heart health with patented textile sensor technology
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection.
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.
Blue Marble Health is telehealth and remote therapeutic monitoring platform for aging and chronic disease management.
Safi Biosolutions is biotechnology based company.
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Actuated Medical is engaged in outsourced research and development, designing, modeling, prototyping, and manufacturing medical devices.
Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics.
RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
National Heart has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Heart's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Pharmaceutical. The firm invests across 32 different industry categories.
Among tracked funding rounds, Perosphere Technologies received $7.5M in a Venture - Series Unknown round. National Heart's total known invested capital is $103.5M.
National Heart's average investment size is $1.9M across its portfolio of 55 companies.
Recent National Heart portfolio additions include Biotricity, Xylyx Bio, Vivita Technologies, Ontogen Medtech, I CORDIS. These companies were founded in 2020 or later.